Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer

Clinical trial NCT06745219 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06745219
Sponsor: Peking University Cancer Hospital & Institute
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Thrombopenia Cervical Cancer Radiotherapy Side Effect Chemotherapeutic Toxicity

Start date: 2025-01-01
Primary completion: 2025-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.